Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016" report to their offering.

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies. Our latest report Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016, outlays comprehensive information on the Protein Phosphatase 2A (PP2A or EC 3.1.3.16) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) Protein Phosphatase 2A (PP2A) is an enzyme encoded by the PPP2CA gene. PP2A plays important roles in regulation of cell cycle, signal transduction, cell differentiation, and transformation. Its activity is related to several diseases, including neurodegenerative diseases and cancer. The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 3 and 2 respectively.

Furthermore, this report also reviews key players involved in Protein Phosphatase 2A (PP2A or EC 3.1.3.16) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

1. Introduction
2. Protein Phosphatase 2A Overview
3. Therapeutics Development
4. Pipeline Products for Protein Phosphatase 2A - Overview
5. Pipeline Products for Protein Phosphatase 2A - Comparative Analysis
6. Protein Phosphatase 2A - Therapeutics under Development by Companies
7. Protein Phosphatase 2A - Therapeutics under Investigation by Universities/Institutes
8. Protein Phosphatase 2A Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Protein Phosphatase 2A - Products under Development by Companies
13. Protein Phosphatase 2A - Products under Investigation by Universities/Institutes
14. Protein Phosphatase 2A - Companies Involved in Therapeutics Development

• Ampio Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• Cyano Biotech GmbH
• Lixte Biotechnology Holdings, Inc.
• Signum Biosciences, Inc.
  

For more information about this report visit http://www.researchandmarkets.com/research/mhbtdx/protein